CD133 was first identified in tumor initial cells (TICs) of glioma, since injection of as few as one hundred CD133+ glioma cells produced a new mass with similar phenotypes to the original tumor, whereas injection of one hundred thousand CD133-glioma cells could not even produce a tumor. The gene discussed is PROM1; the disease is neoplasm.